Gastric Balloon System Market: Gastric balloon system is an innovative non-surgical weight loss procedure in which physicians temporarily places the gastric balloon in the stomach. Gastric balloon system will be placed in the stomach using endoscopy through oesophagus and some of the products are in swallowable capsule form. With the help of gastric balloons, patient feels fluffiness and it enables to reduce the weight. Gastric balloon system is used for patients only when diet and exercise have failed in reducing weight and surgery is not wanted or recommended to the patient.
Gastric Balloon System Market Outlook
According to WHO Global Health Observatory data, 2014 more than 1.9Bn people worldwide and nearly one-quarter of children, adolescents in developed countries are overweight or obese. At least 2.8Mn people each year die as result of overweight or obese and half of the world’s population may be subjected to obesity by 2030. Moreover, increase in the awareness about the consequences related to obesity and chances of getting the other chronic diseases, patients are preferring to lose weight. Apart from aforementioned factors, advances in gastric balloon technology led to safer and cost-effective procedure over the surgical procedures. Along with this, short hospital stay, reducing recovery time, expected to prompt healthcare professionals to choose the gastric balloon systems over other bariatric procedures. However, the adverse events associated with gastric balloon systems such as inflation of balloon, pain, swelling, vomiting, and chances of getting acute pancreatitis are becoming as restrains for Gastric Balloon System Market
Gastric balloon system market is segmented based on product, mode of administration, filling material and end user.
Based on product, gastric balloons system market is segmented into
- Single Intra Gastric Balloon
- Double Intra Gastric Balloon
- Triple Intra Gastric Balloon
Based on filling material, gastric balloons system market is segmented into
- Saline Filling
- Gas Filling
Based on route of administration, gastric balloons system market is segmented into
Based on end user, gastric balloon system market is segmented into
- Bariatric Clinics
- Ambulatory Surgical Centers
Gastric balloon system is in the growth phase, fluid-filled gastric balloon products are having prevalent adverse events when compared to the gas-filled products. In February 2017, U.S. FDA alerted healthcare providers stating about the high prevalence of adverse events with the usage of fluid-filled gastric balloon. Due to the advancements in technology like a development of swallowable capsules forms by Obalon technologies (obalon) and Allurion (elipse), and reducing the risks in using gastric balloon system are increasing the acceptance of gastric balloon system products by patients. These factors are expected to bolster revenue growth in gastric balloon system market.
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among all the regions North America accounts larger share due to more number of obese patients. According to Centers for Disease Control and Prevention (CDC), more than 36% of the US adult population is obese. In Europe increase in prevalence of the obesity and rising demand for weight loss products driving the market revenue growth. Gastric balloon system market in Latin America is growing at significant CAGR due to the rapid increase in healthcare expenditure and increase in the number of doctors. In Asia-Pacific region because of rising in the medical tourism, lower cost of healthcare, and rise in the development of healthcare infrastructure in developing countries like India projects the better growth opportunity for Gastric Balloon System Market players.
Some of the players in the global gastric balloon system market are Allurion Technologies (U.S.), Silimed Inc. (Brazil), Obalon Therapeutics Inc. (U.S.), Districlass Medical (S.A.) (France), and ReShape Medical Inc. (U.S.) to name a few.
- In September 2016, S. FDA approved Obalon Therapeutics Inc.’s obalon balloon system for marketing, this can be swallowed or available in capsule form
- In 2015, Apollo Endosurgery launched orbera and ReShape Medicals launched reshape duo that is very widely used gastric balloon in the market
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario